Chinese furniture and home improvement retail chain EasyHome has raised just over $2bn in a round in which Alibaba invested approximately $860m in return for a 15% stake.
Uber could acquire what sources told CNBC would be a sizeable stake in Southeast Asian counterpart Grab through a deal that will involve Grab taking on its local business.
Procept BioRobotics, the developer of an aquablation treatment for a prostate condition called benign prostatic hyperplasia, has secured $118m in a round led by Viking Global Investors.
Harry’s has been one of the two biggest players in the razor blade subscription market, along with Dollar Shave Club, and the Grace Beauty-backed company has raised $112m in a round that will precede an expansion of the business model into areas like personal care items for both sexes as well as baby products and household goods.
Kallyope, a US-based company developing drugs that focus on the gut-brain axis, received $66m in a series B round featuring Illumina Ventures, the corporate venturing subsidiary of genomics technology producer Illumina.
AI data analytics platform SparkCognition has added $24m from investors including corporate venturing units Invenergy Future Fund and CME Ventures to close its series B round at $56.5m.
Glossier, a US-based skincare and beauty product company backed by talent agency William Morris Endeavor (WME), raised $52m in a series C round yesterday co-led by VC firms IVP and Index Ventures.
Financial services provider Power Financial has invested another $51m in robo-advisor operator WealthSimple, taking its total commitment to $165m according to the latter.
Smart glasses developer OrCam has received $30.4m in funding from investors including Clal Insurance at a reported valuation of about $1bn. OrCam, which counts Intel Capital as an earlier investor, is said to be prepping an IPO for 2019 and will aim to raise one more substantial round of funding before then, having so far secured a total of $130m according to Reuters.
On GUV, Liquidia Technologies, a US-based biopharmaceutical spinout from University of North Carolina at Chapel Hill, has raised $25.5m in funding.
SoftBank Vision Fund has already secured some $40bn from Middle Eastern sovereign wealth funds PIF and Mubadala Investment Company, and now the CEO of Bahraini sovereign wealth fund Mumtalakat has confirmed it too is in talks to invest.
Cove Fund, a family of seed-stage venture capital funds that invests in companies affiliated with University of California (UC) System, has raised more than $12m for its second fund. The figure represents a first close for Cove Fund II, with a regulatory filing indicating a $15m target size.
Switzerland-headquartered biotechnology and chemicals supplier Lonza Group has formed a corporate venturing fund in partnership with US-based venture capital firm Prolog Ventures.
Flatiron Health agreed to an acquisition by investor Roche in mid-February that will involve the latter paying $1.9bn for the company’s outstanding shares, and much of the attention has understandably been on Roche.
And talking of GV’s recent spate of life sciences exits, it looks like the next one will be Arcus Biosciences. Immuno-oncology therapy developer Arcus has filed for a $100m initial public offering, having previously raised some $227m in VC funding.
Social media company Momo agreed today to acquire China-based social engagement platform Tantan for about $760m, allowing media group Bertelsmann and social network operator YY to exit.
Faceu, the developer of an augmented reality app that allows effects to be overlaid on photos or videos in real time, has reportedly been acquired by mobile news platform Toutiao for $300m.
Enterprise cloud security technology provider Zscaler had raised $148m in funding from investors including the Dell-owned EMC and Alphabet unit CapitalG, and has now filed to raise up to $100m in an initial public offering.